ECL  105/412-­‐  the  latest  revolution  in  Coagulation  Analyzers          

 

       Shivdas  Pokkalath    Product  Manager-­‐Coagulation    Transasia  Bio-­‐Medicals  Ltd.  

 

 

Through  thirty  five  years  of  its  existence,  Transasia  Bio-­‐Medicals  Ltd.  has  led  the  Indian  In-­‐vitro  Diagnostic   Industry,   in   offering   quality   products   and   services.   With   an   aim   to   provide  innovations  that  aid  in  timely  and  accurate  diagnosis,  Transasia  regularly  introduces  innovative  and  most  advanced  technology  based  on  the  requirements  of  the  customers.  

The   last   few   years,   have   seen   a   rampant   growth   in   the   Indian   preventive   and   curative  healthcare  industry.  There  are  an  estimated  50,000  clinical  labs  in  cities,  towns,  district,  villages  and  remote  areas,  which  gives  an  indication  of  the  huge  patient  base  and  the  need  to  provide  quality,  dependable  and  timely  diagnostic  services.    

Among  others,  the  most  common  coagulation  tests  performed  include  PT,  aPTT  and  D  Dimer.  The  customer  requirement  is  neatly  classified  into  small,  medium  clinical  labs  and  (component  separation)  blood  banks.  While   in  some   labs,   there   is  a  need  to  perform  PT,  aPTT,   fibrinogen  and  D  Dimer,  others  such  as  blood  banks  routinely  perform  fibrinogen  and  Factor  VIII.  A  set  of  customers  specialized  in  coagulopathy,  do  perform  certain  rare  parameters.  

However,   not   all   systems   in   the   market   are   equipped   to   cater   to   these   requirements.  Additionally,  not  having  small  reagent  pack  sizes  for  D  Dimer  and  unavailability  of  timely  service  in  remote  areas  are  issues  that  need  immediate  attention.    

In   a   step   towards   resolution   of   critical   issues   mentioned   above   and   cater   to   diverse   but  pertinent   customer   needs,   Transasia   recently   launched   two   advanced   coagulation   analyzers,  ECL  105  –  Single  Channel  and  ECL  412  –  Four  Channel.  Both  these  analyzers  use  an  innovative  technology  thereby  givi  ng  most  accurate/precise  results  at  extremely  affordable  costs.  

                                                       

                                                                 

 

Key  highlights/features  of  both  the  instruments  include:    

Hardware  -­‐  Easy  to  operate  LCD  touch  screen  graphical  display  -­‐  Built-­‐  in  incubator  for  cuvette  -­‐  Facility  for  reagent  incubation  through  magnetic  stirring  of  reagents.  Especially  beneficial  for  mixing        silica  or  latex  based  reagents  as  they  require  constant  stirring  to  keep  the  particulate  matter  suspended                      in  solution  -­‐  Inbuilt  robust  thermal  printer  

-­‐  Easy  connectivity  through  USB  ports,  Ethernet  ports  and  RFID  detection  facility  -­‐  Storage  of  data  and  coagulation  clotting  curves  is  possible  on  an  external  drive  -­‐  Test  menu  includes  comprehensive  range  of  tests  from  clotting  to  chromogenic*  and        immunologic  tests(*only  on  ECL  412)  -­‐  Light  scattering  principle  is  used  for  performing  the  assays-­‐  Clotting  (640  nm),  Chromogenic  (405  nm)      and  D  Dimer  (800  nm)  

Software  -­‐  Intuitive,  user-­‐friendly,  with  minimal  simple  logical  inputs  in  programming  tests,  multi-­‐standard        calibration,  plotting  multilevel  QC  points  and  running  tests  -­‐  Proven  technology  of  coagulation  curve  in  percentage  light  scatter  for  clot  detection        The  ERBA  ECL  105/  412  performs  the  most  comprehensive  coagulation  tests  in  semi-­‐automated  systems.  The  tests  such  as  Fibrinogen,  Factors  assays,  Lupus  anticoagulant,  Protein  C  ,  Protein  S,  AT  III*  and  D  Dimer  are  programmed  and  can  be  performed  with  minimum  effort  (  *  only  on  ECL  412).      

The  QC  plotting  has  been  programmed  keeping  in  mind  the  accreditation  requirement  of  laboratory.  Multilevel  QC  for  each  test  is  possible,  a  feature  still  rare  in  many  single  and  four  channel  analyzers.  

With  all  its  advanced  features,  ERBA  ECL  105/  412  is  equipped  to  perform  complete  range  of  hemostasis  tests  and  give  its  end-­‐users  the  freedom  to  choose  the  test  of  their  choice.    

_____________________________________________________________________________________  

About  Transasia  Bio-­‐Medicals  Ltd.    

Incepted   in  the  year  1979,  Transasia  Bio-­‐Medicals  Ltd.,   is  headquartered   in  Mumbai,   India.   It   is  one  of  India’s   largest   In-­‐vitro   Diagnostic   Company   and   offers   solutions   and   products   in   Biochemistry,  Hematology,   Coagulation,   ESR,   Immunology,   Urinalysis,   Critical   Care,   Diabetes   Management   and  Microbiology.   Infact,   Transasia   is   the   first   Indian   company   to   manufacture   and   export   sophisticated,  state  of  the  art  blood  analyzers  and  reagents.  

Transasia  is  a  part  of  the  global  ERBA  Diagnostics  Mannheim  GmbH  Group.  The  ERBA  Group  has  spread  its   footprint   across  USA,   Europe,   Turkey   and   Eastern   Europe,   Russia   and   France,   by  means  of   various  acquisitions   –   ERBA   Lachema   s.r.o.(Czech   Republic),   ERBA   Rus(Russia),   ERBA   Diagnostics,   Inc.   (USA),  Diamedix  Corporation  (USA),  Delta  Biologicals,S.r.l  (Italy),  ImmunoVision,  Inc.  (USA),  Erba  DDS  (Turkey),  ERBA  Diagnostics  France  (France),  JAS  Diagnostics  Inc.  (USA)  and  Drew  Scientific  (USA).  

Transasia  manufactures  and  markets  equipment  and  reagents,  with  an  impressive  install  base  of  above  45,000  equipments  across  India.  Transasia  also  exports  to  more  than  100  countries  in  five  continents.    

The  vast  network  of  more  than  150  service  engineers,  350+  Sales  and  Marketing  Team,  14  zonal  offices,  and  350+  Distributors  allows  us  to  reach  out  to  customers  across  the  length  and  breadth  of  the  country.      

Alliances   with   international   partners   like   Sysmex   Corporation   (Japan),   Medica   (USA),   Diesse   (Italy),  Immco  Diagnostics   (USA)   and  Wako   (Japan)   have   ensured   that   cutting   edge   technology   and   solutions  

can  be  brought  to  India.  Transasia  markets,  services  and  supports  the  Sysmex  products  and  solutions  in  India.  (www.transasia.co.in)  

Transasia’s   commitment   to   healthcare   has   been   recently   recognized   by   the   World   Economic   Forum  which  conferred  the  organization  with  ‘Global  Growth  Company  Award,  2014’.    

With   a   vision   of   being   recognized   as   a   ‘local   for   global’   organization,   Transasia   continues   to   provide  doctors  and  patients  with  reliable,  affordable  and  innovative  Medical  Diagnostic  Systems.  

_____________________________________________________________________________________